It is estimated that about 60,000 people in the U.S. are currently living with FTD. Up to 40% of FTD cases have a genetic component and the patient receiving troculeucel is known to carry the C9orf72 ...
With the U.S. withdrawing from the World Health Organization and rethinking foreign aid, China has an opportunity to play a ...
When President Trump took office, his administration instituted an external communications blackout across health agencies.
One of the partnerships involves technology transfer between two African companies to develop new mRNA vaccines to address ...
New research reveals tricaprin, a natural supplement found in coconut oil and dairy, significantly improves survival rates and heart function in TDCV patients.
Japan's AMR response from 2013 to 2025 focuses on surveillance, antimicrobial stewardship, infection prevention, and research ...
KFDA launches Global Harmonization Center to enhance food and pharma safety KFDA establishes a new center to foster global safe practices in food and pharmaceuticals ...
CanSino Biologics Inc. (CanSinoBIO or the Company), a leading Chinese vaccine innovator, has been invited to the 2025 World ...
Liberia’s health system has heavily depended on the United States Agency for International Development (USAID). USAID has invested more than three billion dollars in humanitarian, development, and ...
The goal of palliative care is to manage this pain effectively. Opioid analgesics are considered the most effective treatment ...
The BBC World Service has launched the Arabic edition of its award-winning educational programme, 'Dars,' (lesson) in the ...
US FDA grants fast track designation to NKGen Biotech’s natural killer cell therapy, troculeucel to treat moderate Alzheimer’s disease: Santa Ana, California Saturday, Februar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback